Group Medicine Appointments Effective for Glycemic Control

This article originally appeared here.
Share this content:
Group Medicine Appointments Effective for Glycemic Control
Group Medicine Appointments Effective for Glycemic Control

WEDNESDAY, Nov. 18, 2015 (HealthDay News) -- Medical management delivered via group medical appointments (GMAs) appears to be effective for glycemic control in patients with type 2 diabetes, according to research published in the November issue of Diabetes Spectrum.

Cora A. Caballero, N.P., from Loma Linda Healthcare System in California, and colleagues conducted an electronic chart review comparing GMA care for 52 male patients with usual primary care for 52 male patients, all with type 2 diabetes. Demographic and health-related variables were analyzed.

The researchers found that the target hemoglobin A1c goals were reached by a greater proportion of GMA patients than usual primary care patients (50 versus 19.2 percent; P = 0.001). The rate of decline of hemoglobin A1c over time was significantly faster for GMA participants versus usual primary care participants (P < 0.001).

"This study demonstrated that the concept of medical management delivered in a group approach had a positive effect on glycemic control in patients with type 2 diabetes," the authors write. "GMAs were found to be an effective approach to achieving patient-centered goals for improving the glycemic control of patients with type 2 diabetes."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »